Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Integrated Characterization of lncRNA-Immune Interactions in Prostate Cancer

16 Feb 2021

Abstract excerpt

Prostate cancer is among the top mortality factors in male around the world. Long non-coding RNAs (lncRNAs) have been shown to play crucial roles in tumor biology and immunology. However, lncRNA-immune interactions have not yet examined in prostate cancer. Here, we performed integrated analysis to characterize lncRNA-immune interactions in prostate cancer through multidimensional aspects, including immune-related...

Topics

Join the communities discussing this publication.

Cancer-related molecular mechanisms research
Circular RNAs in diseases
Prostate Cancer Treatment and Research

Source

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Identifiers

PMID: 33665192
DOI: 10.3389/fcell.2021.641891

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 31 Aug 2026.

Community interpretation

Discuss the evidence

Ask a question, add context or challenge an interpretation. Community activity is separate from scientific evidence strength.

0

discussions

0

replies

Citations encouraged

Claims remain attributable.

No discussion yet

Be the first to add a careful, cited interpretation.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Integrated Characterization of lncRNA-Immune Interactions in Prostate CancerPMID 33665192Read ↗

Development of a Novel Immune-Related Prognostic Signature for Prostate CancerSemantic proximity Read ↗

Molecular Landscape of LncRNAs in Prostate Cancer: A focus on pathways and therapeutic targets for interventionSemantic proximity Read ↗

Tumor-antigens and immune landscapes identification for prostate adenocarcinoma mRNA vaccineSemantic proximity Read ↗

Coordinating single‐cell and bulk RNA ‐seq in deciphering the intratumoral immune landscape and prognostic stratification of prostate cancer patientsSemantic proximity Read ↗

Deciphering the suppressive immune microenvironment of prostate cancer based on CD4+ regulatory T cells: Implications for prognosis and therapy predictionSemantic proximity Read ↗

Prostate cancer biomarker analysis and drug target prediction based on bioinformatics analysisSemantic proximity Read ↗

Comprehensive analysis of tumor mutation burden and immune microenvironment in prostate cancer.Semantic proximity Read ↗

Prioritization of prostate cancer to immune checkpoint therapy by ranking tumors along IFN-γ axis and identification of immune resistance mechanismsSemantic proximity Read ↗

Prognostic Value of Genes and Immune Infiltration in Prostate Tumor MicroenvironmentSemantic proximity Read ↗

Prostate Cancer-Induced Remodeling of the Topologies and Interplay of the TLR (Toll-Like Receptor) and Chemokine Signaling PathwaysSemantic proximity Read ↗

Construction of an immune‐related LncRNA signature with prognostic significance for bladder cancerSemantic proximity Read ↗

Immune-related biomarker risk score predicts prognosis in prostate cancer.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.